H.C. Wainwright raised the firm’s price target on Sensus Healthcare (SRTS) to $11 from $10 and keeps a Buy rating on the shares. The company reported a top- and bottom-line beat in Q3 amid strong momentum in the Fair Deal agreement, As previously reported,
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter